Smith & Nephew plc develops, manufactures, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder.
Read More…
Industry, Sector and Symbol
Industry Medical Appliances & Equipment
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+44-20-74017646
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales£4.95 billion
Profitability
Miscellaneous
Employees16,377
Next Earnings DateN/A
OptionableOptionable
Smith & Nephew (LON:SN) Frequently Asked Questions
What is Smith & Nephew's stock symbol?
Smith & Nephew trades on the London Stock Exchange (LON) under the ticker symbol "SN."
How often does Smith & Nephew pay dividends? What is the dividend yield for Smith & Nephew?
Smith & Nephew declared a dividend on Wednesday, July 31st. Investors of record on Thursday, October 3rd will be given a dividend of GBX 0.14 per share on Wednesday, October 30th. This represents a yield of 0.62%. The ex-dividend date of this dividend is Thursday, October 3rd. The official announcement can be seen at this link. View Smith & Nephew's Dividend History.
What price target have analysts set for SN?
10 Wall Street analysts have issued 12-month target prices for Smith & Nephew's shares. Their forecasts range from GBX 1,350 to GBX 1,830. On average, they expect Smith & Nephew's share price to reach GBX 1,551.11 in the next twelve months. This suggests that the stock has a possible downside of 17.6%. View Analyst Price Targets for Smith & Nephew.
What is the consensus analysts' recommendation for Smith & Nephew?
10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Smith & Nephew in the last year. There are currently 1 sell rating, 8 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Smith & Nephew.
Has Smith & Nephew been receiving favorable news coverage?
Media stories about SN stock have trended somewhat positive this week, InfoTrie Sentiment reports. The research firm identifies positive and negative media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Smith & Nephew earned a media sentiment score of 0.9 on InfoTrie's scale. They also gave headlines about the company a news buzz of 1.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for Smith & Nephew.
Who are some of Smith & Nephew's key competitors?
Some companies that are related to Smith & Nephew include Corindus Vascular Robotics (CVRS), Consort Medical (CSRT), Ekf Diagnostics (EKF), Immunodiagnostic Systems (IDH), Theralase Technologies (TLT), Intelligent Ultrasound Group (MED), LiDCO Group (LID), Deltex Medical Group (DEMG), Zecotek Photonics (ZMS), InspireMD (NSPR), Lucid (LCDX), MCP Income Opp Trust Ordinary Units FP (MOT) and Verisante Technology (VRS).
What other stocks do shareholders of Smith & Nephew own?
Who are Smith & Nephew's key executives?
Smith & Nephew's management team includes the folowing people:
- Mr. Namal Nawana, CEO & Exec. Director (Age 48)
- Mr. Graham Timothy Baker, CFO & Exec. Director (Age 51)
- Mr. Mark Gladwell, Pres of Global Operations (Age 44)
- Ms. Catheryn O'Rourke, Chief Legal & Compliance Officer (Age 46)
- Mr. Joe Metzger, Sr. VP of Marketing Services & Communications
How do I buy shares of Smith & Nephew?
Shares of SN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Smith & Nephew's stock price today?
One share of SN stock can currently be purchased for approximately GBX 1,882.
How big of a company is Smith & Nephew?
What is Smith & Nephew's official website?
How can I contact Smith & Nephew?
Smith & Nephew's mailing address is 15 Adam Street, LONDON, WC2N 6LA, United Kingdom. The company can be reached via phone at +44-20-74017646.
MarketBeat Community Rating for Smith & Nephew (LON SN)
MarketBeat's community ratings are surveys of what our community members think about Smith & Nephew and other stocks. Vote "Outperform" if you believe SN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SN will underperform the S&P 500 over the long term. You may vote once every thirty days.
